Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;7(3):279-86.
doi: 10.1071/SH09130.

Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence

Affiliations

Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence

Ingrid T Katz et al. Sex Health. 2010 Sep.

Abstract

This review article provides a conceptual framework for human papillomavirus (HPV) vaccine acceptance and adherence, with a focus on improving understanding of the sociocultural factors impacting vaccine adherence behaviour. We include a systematic review of the slowly expanding literature on HPV vaccine acceptability and uptake in developed nations, as well as the relatively few publications from poorer nations, where more than 80% of global cervical cancer related deaths occur and where the vaccine will probably have the largest impact. We suggest that this conceptual framework will not only improve our understanding of HPV vaccine uptake and adherence, but it may also guide future sociobehavioural research geared towards improving adherence to the HPV vaccine and other multi-step vaccines in a young population at risk for sexually transmissible infections.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

None declared.

Figures

Fig. 1
Fig. 1
The Vaccine Perceptions, Accountability and Adherence Model.

Similar articles

Cited by

References

    1. Muñoz N, Castellsagué X, de González AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006;24:1–10. - PubMed
    1. Baden LR, Curfman GD, Morrissey S, Drazen JM. Human papillomavirus vaccine – opportunity and challenge. N Engl J Med. 2007;356:1990–1. doi: 10.1056/NEJMe078088. - DOI - PubMed
    1. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–27. doi: 10.1056/NEJMoa021641. - DOI - PubMed
    1. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030–44. doi: 10.1002/ijc.21731. - DOI - PubMed
    1. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, Ghissassi F. Carcinogenicity of human papillomavirus. Lancet Oncol. 2005;6:204. doi: 10.1016/S1470-2045(05)70086-3. - DOI - PubMed

Publication types

MeSH terms

Substances